Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions
- PMID: 34515817
- DOI: 10.1007/s00198-021-06064-5
Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions
References
-
- Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RLM, Tan M, Ruzycky ME, Su G, Eastell R (2012) The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 27(2):243–254. https://doi.org/10.1002/jbmr.1494 - DOI
-
- Black DM, Reid IR, Cauley JA et al (2015) The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 30(5):934–944. https://doi.org/10.1002/jbmr.2442 - DOI - PubMed
-
- Ryder HF, McDonough C, Tosteson ANA, Lurie JD (2009) Decision analysis and cost-effectiveness analysis. Semin Spine Surg 21(4):216–222. https://doi.org/10.1053/j.semss.2009.08.003 - DOI - PubMed - PMC
-
- Sanders GD, Neumann PJ, Basu A et al (2016) Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 316(10):1093–1103. https://doi.org/10.1001/jama.2016.12195 - DOI - PubMed
-
- Adami G, Jaleel A, Curtis JR et al (2020) Temporal trends and factors associated with bisphosphonate discontinuation and restart. J Bone Miner Res 35(3):478–487. https://doi.org/10.1002/jbmr.3915 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
